Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Coalition for a Competitive Pharmaceutical Market CCPM
CCPM Lauds President Obama for Supporting Reasonable Exclusivity in Recommendations on Biogeneric Pathway
March 21st, 2009
The Coalition for a Competitive Pharmaceutical Market (CCPM) applauds President Obama for his commitment to a workable biogeneric pathway with an exclusivity period modeled after Hatch-Waxman in his new budget released. “President Obama recognizes that a workable pathway balances access to high quality biologic medicines with continued incentives for true innovation in the same way that Hatch-Waxman did twenty-five years ago. We appreciate the President’s leadership on this issue and his recognition that the Hatch-Waxman model provides the appropriate balance between innovation and access and not the 14 year exclusivity period that has been proposed,” said CCPM Chair...
Source: Law & Health Weekly (2009-03-21)
|
